Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

详细信息    查看全文

• 作者：Hasan Korkaya ; Gwang-il Kim ; April Davis ; Fayaz Malik ; N.?Lynn Henry ; Suthinee Ithimakin ; Ahmed?A. Quraishi ; Nader Tawakkol ; Rosemarie D'Angelo ; Am ; a K. Paulson ; Susan Chung ; Tahra Luther ; Hayley?J. Paholak ; Suling Liu ; Khaled A. Hassan ; Qin Zen ; Shawn?G. Clouthier ; Max?S. Wicha
• 刊名：Molecular Cell
• 出版年：2012
• 出版时间：24 August, 2012
• 年：2012
• 卷：47
• 期：4
• 页码：570-584
• 全文大小：2154 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Although inactivation of the PTEN gene has been implicated in the development of resistance to the HER2 targeting antibody trastuzumab, the mechanisms mediating this resistance remain elusive. We generated trastuzumab resistant cells by knocking down PTEN expression in HER2 overexpressing breast cancer cell lines and demonstrate that development of trastuzumab resistance in these cells is mediated by activation of an IL6 inflammatory feedback loop leading to expansion of the cancer stem cell (CSC) population. Long term trastuzumab treatment generates highly enriched CSCs which display an EMT phenotype secreting over 100-fold more IL6 than parental cells. An IL6 receptor antibody interrupted this inflammatory feedback loop reducing the cancer stem cell population resulting in decreased tumor growth and metastasis in mouse xenographs. These studies demonstrate that trastuzumab resistance may be mediated by an IL6 inflammatory loop and suggest that blocking this loop may provide alternative strategy to overcome trastuzumab resistance.